Dexelvucitabine
An antiretroviral drug
| Dexelvucitabine | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Dexelvucitabine is a nucleoside reverse transcriptase inhibitor (NRTI) that was investigated for the treatment of HIV/AIDS. It is a synthetic analog of cytosine and was developed to inhibit the replication of the human immunodeficiency virus (HIV) by interfering with the viral reverse transcriptase enzyme.
Mechanism of Action[edit | edit source]
Dexelvucitabine works by mimicking the natural nucleosides that are used by the reverse transcriptase enzyme to synthesize viral DNA. Once incorporated into the growing DNA chain, dexelvucitabine acts as a chain terminator, preventing further elongation of the viral DNA. This inhibition of viral DNA synthesis ultimately reduces the viral load in patients.
Development and Clinical Trials[edit | edit source]
Dexelvucitabine was developed in the early 2000s and underwent several phases of clinical trials. Initial studies showed promise in reducing viral load in patients with HIV. However, further trials revealed concerns about potential toxicity and adverse effects, which led to the discontinuation of its development.
Adverse Effects[edit | edit source]
During clinical trials, dexelvucitabine was associated with several adverse effects, including lactic acidosis, hepatomegaly, and steatosis. These side effects were significant enough to halt further development of the drug.
Chemical Properties[edit | edit source]
Dexelvucitabine is a synthetic analog of cytosine, with modifications that allow it to act as a reverse transcriptase inhibitor. Its chemical structure is designed to enhance its ability to be incorporated into viral DNA, while also aiming to reduce its degradation by cellular enzymes.
Related pages[edit | edit source]
Dexelvucitabine[edit | edit source]
Dexelvucitabine
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
